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ORIGINAL ARTICLE
Substance use, sleep and intervention design: insights from
qualitative data
Joanne Neale1, Robert Meadows2, Sarah Nettleton3, Daria Panebianco1, John Strang1, Silia Vitoratou4 and
John Marsden1
1National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK, 2Department of Sociology,
University of Surrey, Guildford Surrey, UK, 3Department of Sociology, University of York, Heslington York, UK, and 4Department of Biostatistics and
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Abstract
Background: Alcohol and other drug use is associated with poor sleep quality and quantity, but
there is limited qualitative research exploring substance users’ experiences of sleep and few
psychosocial sleep interventions for them.
Aim: To inform the development of psychosocial interventions to improve sleep amongst
people reporting drug/alcohol problems.
Method: Qualitative data were collected during a sleep survey. Of the 549 drug/alcohol users
completing the survey, 188 (34%) provided additional information about their sleep using a
free text box. Responses were analysed via Iterative Categorisation. Findings were reviewed
with reference to the Behaviour Change Wheel (BCW).
Results: All data were categorised inductively under five headings: (i) sleep quality; (ii) nature of
sleep problems; (iii) sleep and substances; (iv) factors improving sleep quality; (v) factors
undermining sleep quality. Substance use undermined sleep, but poor sleep often persisted
after substance use had ceased. Sleep problems were diverse; as were the causes of, and
strategies for dealing with, those problems. Causes and strategies had biological, psychological,
social and environmental roots.
Conclusions: The BCW facilitated the identification of intervention components that might
improve the sleep of people who use substances. These components relate to education,
training, enablement, modelling, service provision, guidelines and environment.
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Introduction
Illicit and non-medical psychoactive substance use is linked to
poor sleep quality and quantity (Arnedt et al., 2012; Burke
et al., 2008; Escobar-Cordoba et al., 2009; Hasler et al.,
2014). Nonetheless, there is limited qualitative research on
substance users’ subjective experiences of sleep. Exceptions
to this include studies exploring linkages between sleep and
recovery from heroin use (Neale et al., 2012; Nettleton et al.,
2011) and sleep in residential drug and alcohol treatment
settings (Nettleton et al., 2017). This research has found that
opiate users want to sleep better, and complain that sleep
problems cause them to feel distressed, exhausted and unable
to cope (Neale et al., 2012; Nettleton et al., 2011, 2017).
Analyses have also shown that ‘‘sleep’’ and ‘‘awake’’ are not
dichotomous states; rather, sleep in residential drug and
alcohol treatment is a complex ‘‘practice’’ or ‘‘assemblage’’
including worrying, resting, fidgeting, thinking, clock watch-
ing, smoking, chatting, dozing and dreaming (Nettleton et al.,
2017).
Increasingly, researchers and clinicians are developing
psychosocial interventions to assist people in changing their
health-related behaviours in ways that should improve their
broader quality of life and well-being. Psychosocial interven-
tions are commonly used in treating substance use disorders
(Babor et al., 2007; Cooper et al., 2015; Higgins & Petry,
1999; Li et al., 2016; Magill & Ray, 2009) and sleep problems
(Baron et al., 2017; Ellis et al., 2015; Morin et al., 1999).
There are, however, few psychosocial interventions explicitly
designed to improve the sleep of people who report a problem
with drugs or alcohol. Cognitive-behavioural therapies tar-
geting insomnia in adult patients with alcohol use disorders
have been developed, but these do not necessarily change
drinking behaviours (Arnedt et al., 2011; Currie et al., 2004)
or reduce relapse to drinking (Roth, 2009) even if they
improve sleep in this population (Brower, 2015). A meta-
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analysis of behavioural therapies for alcohol-related disorders
and accompanying sleep disturbances has, meanwhile,
reported that methodological weaknesses limit the conclu-
sions that can be drawn regarding intervention efficacy and
there is a need for patient-centred research, including
qualitative methods, to inform future intervention develop-
ment (Brooks & Wallen, 2014).
One recognised method for characterising and designing
behaviour change interventions is the behaviour change wheel
(BCW;Michie et al., 2011). At the centre of the BCWare three
conditions required to modify behaviour: ‘‘Capability’’,
‘‘Opportunity’’ and ‘‘Motivation’’, collectively known as
the COM-B system. The COM-B system is surrounded
by nine intervention functions: ‘‘Education’’, ‘‘Persuasion’’,
‘‘Incentivisation’’, ‘‘Coercion’’, ‘‘Training’’, ‘‘Enablement’’,
‘‘Modelling’’, ‘‘Environmental Restructuring’’ and
‘‘Restrictions’’. These nine intervention functions address
deficits in one or more of the three behavioural conditions.
The outer circle of the BCW then comprises seven policy
categories: ‘‘Guidelines’’, ‘‘Environmental/Social Planning’’,
‘‘Communication/Marketing’’, ‘‘Legislation’’, ‘‘Service
Provision’’, ‘‘Regulation’’ and ‘‘Fiscal Measures’’. The seven
policy categories facilitate the nine intervention functions.
The BCW offers a more comprehensive analytical frame-
work than most other frameworks of behaviour change since it
does not restrict itself to cognitive processes, but instead
understands behaviour in relation to its context, including the
social and physical environment. If applied theoretically to
sleep, the BCW would posit that to change their sleep pattern
an individual would require the physical and psychological
‘‘Capability’’ and knowledge to sleep differently; an envir-
onment, financial circumstances and social relationships that
afford ‘‘Opportunity’’ to sleep differently; and autonomic
desires or impulses as well as self-conscious, self-directed
‘‘Motivations’’ to sleep differently. If any of these compo-
nents were weak or absent, interventions and policies would
be needed to increase the individual’s resources, such that a
change in sleep would become possible.
The aim of this paper is to inform the development of
psychosocial interventions to improve sleep amongst people
reporting drug or alcohol problems. Service user voices are
often absent when research and intervention development
agendas are set (Robotham et al., 2016; Trivedi & Wykes,
2002), and we here seek to counter this by exploring the
accounts of people who identify as having (or having had) a
problemwith drugs and/or alcohol.We also reviewour findings
with reference to the BCW. Although the BCW has not
previously been used to explore sleep amongst people who use
substances, it has been reliably applied to other public health
interventions, such as tobacco control and obesity (Michie et al.,
2011).Moreover, it fitswellwith the extant qualitative research,
which has emphasised that sleep amongst drug and alcohol
users is a complex material, social, normative and affective
practice – not simply a cognitive process (Nettleton et al., 2017).
Methods
Data were generated via a short self-complete survey
conducted as part of a wider study designed to produce a
new Patient Reported Outcome Measure (PROM) of sleep
quality amongst people in recovery from drug and/or alcohol
dependence (Neale & Strang, 2015a,b). Development and
validation of the PROM will be reported separately. The
survey was open to any current or former drug or alcohol user,
without any pre-screening for sleep problems. The survey was
undertaken in paper format in community drug and alcohol
treatment services, homelessness services and peer support
services in three UK cities between December 2015 and May
2016. It was also made available for online completion
between April 2016 and July 2016 (a link to the survey was
circulated to service user organisations and treatment services
via social media and email). Participants who completed the
paper version were offered refreshments to compensate for
their time. No compensation was offered to those completing
the survey online.
At the end of the survey, there was a free text box inviting
respondents to ‘‘write anything else you would like to tell us
about your sleep’’. In total, 549 individuals completed the
survey (442 on paper and 107 online). Of these, 188 (34%)
provided additional information about their sleep using the
free text box (four others provided responses that could not be
interpreted so these had to be deleted). Basic demographic,
substance use and sleep characteristics of all individuals
completing the survey are shown in Table 1. Given the diverse
range of substances used (depressants, stimulants, hallucino-
gens and analgesics; in different quantities and often in
complex and changing combinations) and the varying lengths
of problem substance use and abstinence reported, respond-
ents were categorised pragmatically based on their self-
reported behaviour in the last 6months: ‘‘no substances’’;
‘‘only drugs’’; ‘‘only alcohol’’ and ‘‘both drugs and alcohol’’.
Table 1 shows significant differences between the 188
respondents providing analysable free text responses and the
357 who did not write any free text. Individuals providing free
text responses were more likely to be female (2¼ 8.865,
df¼ 1, p¼ 0.003), White (2¼ 6.792, df¼ 1, p¼ 0.009),
older (t¼3.551, df¼ 424.44, p50.001), abstinent/not using
drugs only in the last 6months (2¼ 22.303, df¼ 3,
p50.001), not homeless (2¼ 5.748, df¼ 1, p¼ 0.017), in
paid work (2¼ 6.841, df¼ 1, p¼ 0.009) and diagnosed with
insomnia (2¼ 4.121, df¼ 1, p¼ 0.042). They included 102
(54.3%) males and 86 (45.7%) females; were mostly White
(n¼ 165 or 87.8%), had a mean age of 47 years (range 24–
71 years), and said that they had had a problem using
substances for a mean of 20 years (range 0–50 years). In the
last 6months, 40 (21.3%) reported a problem with drugs, 55
(29.3%) reported a problem with alcohol, 37 (19.7) reported a
problem with both drugs and alcohol and 56 (29.9%) reported
no problem substance use. In the last month, 17 (9.0%) had
been homeless, 43 (22.9%) had had paid legal work and 17
(9.1%) had been in residential treatment. In total, 50 (26.6%)
had ever been diagnosed as having a sleep disorder (sleep
apnoea, narcolepsy, restless legs syndrome or insomnia).
The 188 free text responses (range¼ 1 to 319 words) were
exported into a Microsoft Word document and analysed
inductively using Iterative Categorisation (Neale, 2016). This
involved reviewing all text segments line-by-line, distilling
the essence of all text segments into simple statements, then
iteratively ordering, re-ordering and grouping all statements
into meaningful categories. Once complete, all content was
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successfully categorised under five headings: (i) sleep quality,
(ii) nature of sleep problems, (iii) sleep and substances,
(iv) factors improving sleep quality and (v) factors under-
mining sleep quality. We use these five headings to structure
our findings below, and include free text extracts to illustrate
key points. The text extracts are labelled with each respond-
ent’s gender, age and substance(s) use in the last 6 months. In
the ‘‘Discussion’’ section, the BCW is used to help interpret
our findings.
Findings
(i) Sleep quality
Respondents mostly referred to their sleep in negative or very
negative terms; emphasising that they did not get enough
sleep, and desperately wanted to sleep ‘‘better’’, ‘‘longer’’,
‘‘properly’’ or ‘‘less erratically’’. For some, the inability to
sleep well was described as slowly ‘‘killing them’’ or as
‘‘torture’’:
I wish I could sleep better. [Male, 39 years, drug use]
It is a mental torture. [Female, 59 years, alcohol use]
Relatively few respondents said that their current
sleep was ‘‘good’’ or that they woke up ‘‘refreshed’’ or
‘‘energetic’’. Instead, they described feeling constantly tired
and exhausted. Some expressed exasperation and/or frus-
tration that they could not maintain a paid job or function
effectively during the day because of tiredness. Others
explained that they ‘‘napped’’ or drank large quantities of
caffeine to keep themselves alert – although they
recognised that this then inhibited their sleep the following
evening:
I wake around 4am and spend the day tired.’’ [Male, 45
years, drug use]
I am exhausted most of the time.’’ [Female, 36 years, drug
and alcohol use]
Table 1. Demographic, substance use and sleep characteristics.
Respondents
without free text
comments (n¼ 357)
Respondents with
free text comments
(n¼ 188)a All sample (n¼ 549) Comparison
Gender
Males 240 (67.2%) 102 (54.3%) 342 (62.8%) 2¼ 8.865, df¼ 1, p¼ 0.003
Females 117 (32.8%) 86 (45.7%) 203 (37.2%)
Ethnicity
White (British, Irish, Other) 281 (78.7%) 165 (87.8%) 446 (81.8%) 2¼ 6.792, df¼ 1, p¼ 0.009
Other 76 (21.3%) 23 (12.2%) 99 (18.2%)
Age (years)
Mean 43.5 46.5 44.5 t¼3.551, df¼ 424.44, p50.001
SD 10.1 8.9 9.8
Range (min-max) 46 (20-66) 47 (24-71) 51 (20-71)
Years with drug/alcohol problems
Mean 20.1 19.99 20.1 t¼ 0.116, df¼ 423.258 p¼ 0.908
SD 11.4 10.1 10.9
Range (min-max) 47 (0-47) 50 (0-50) 50 (0-50)
Any substance use in the last 6 months
None 49 (13.8%) 56 (29.9%) 105 (19.4%) 2¼ 22.303, df¼ 3, p50.001
Only drugs 105 (29.7%) 40 (21.3%) 145 (26.8%)
Only alcohol 103 (29.1%) 55 (29.3%) 158 (29.2%)
Both drugs and alcohol 97 (27.4%) 37 (19.7%) 134 (24.7%)
Homeless in the last month
No 298 (83.5%) 171 (91.0%) 469 (86.1%) 2¼ 5.748, df¼ 1, p¼ 0.017
Yes 59 (16.5%) 17 (9.0%) 76 (13.9%)
Paid legal work in the last month
No 307 (86.0%) 145 (77.1%) 452 (82.9%) 2¼ 6.841, df¼ 1, p¼ 0.009
Yes 50 (14.0%) 43 (22.9%) 93 (17.1%)
Residential treatment in the last month
No 310 (87.1%) 170 (90.9%) 480 (88.6%) 2¼ 1.554, df¼ 1, p¼ 0.213
Yes 45 (12.9%) 17 (9.1%) 62 (11.4%)
Ever diagnosed with sleep apnoea
No/Don’t know 338 (95.5%) 185 (98.4%) 522 (96.5%) 2¼ 3.122, df¼ 1, p¼ 0.077
Yes 16 (4.5%) 3 (1.6%) 19 (3.5%)
Ever diagnosed with narcolepsy
No/Don’t know 349 (98.9%) 185 (98.4%) 534 (98.7%) Fisher’s exact test: p¼ 0.699
Yes 4 (1.1%) 3 (1.6%) 7 (1.3%)
Ever diagnosed restless legs syndrome
No/Don’t know 325 (92.1%) 172 (91.5%) 497 (91.9%) 2¼ 0.055, df¼ 1, p¼ 0.815
Yes 28 (7.9%) 16 (8.5%) 44 (8.1%)
Ever diagnosed with insomnia
No/Don’t know 294 (83.3%) 143 (76.1%) 437 (80.8%) 2¼ 4.121, df¼ 1, p¼ 0.042
Yes 59 (16.7%) 45 (23.9%) 104 (19.2%)
aAn additional four individuals provided responses that could not be interpreted so are treated as missing.
The exact significance is stated in the bold font.
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(ii) Nature of sleep problems
When respondents elaborated on the type of sleep prob-
lems they experienced, the main difficulty identified was
poor quality sleep occasioned by constantly waking up in the
night:
I wake up several times every night.’’ [Male, 56 years, no
substance use]
I wake up too often. [Male, 45 years, alcohol use]
In addition, many complained of frightening night-
mares, vivid dreams and hallucinations that unsettled them
throughout the next day. These often related to people they
knew and situations that they considered to be stressful,
including being in treatment and detoxing:
I hate the disturbing dreams I have. [Female, 36 years, no
substance use]
Sometimes I get hallucinations. [Male, 54 years,
alcohol use]
Some respondents complained of sleeping too much and
yet still feeling tired, or of collapsing exhausted onto the bed
at all times of day and night. In contrast, several others
bemoaned prolonged periods of not sleeping at all, sometimes
for days and weeks at a time:
At the moment I seem to sleep too much and still feel tired.
[Male, 53 years, no substance use]
I can go long periods of time without sleep, ranging from
two days to as long as four, possibly five, days. [Male, 24
years, alcohol use]
Whilst respondents often spoke of difficulties falling
asleep, few complained of early morning wakening:
It takes ages to get sleep. [Female, 55 years, alcohol use]
I can’t quiet my brain to sleep on my own. [Female, 43
years, no substance use]
(iii) Sleep and substances
Links between sleep and substance use, but also between
sleep and the use of prescribed medications, were repeatedly
emphasised. These relationships were, however, complex and
contradictory. Thus, many respondents attributed sleep prob-
lems to their drinking or drug use, or indicated that drinking
or drug use exacerbated prior sleep problems:
I used to have lots of trouble with sleep when I was
drinking. [Female, 43 years, no substance use]
The deep, prolonged sleep I experienced under the
influence of heroin was not natural. [Male, 47 years, no
substance use]
Despite this, several respondents stated that they used street
drugs (particularly cannabis) or alcohol either just before bed
or during the night to help them sleep; often adding that
without these substances they could not sleep:
I smoke cannabis to help me get to sleep. [Female, 25
years, drug and alcohol use]
I use cannabis in the night to sleep. [Male, 43 years,
drug use]
Respondents also frequently reported that they took
prescribed medications (especially anti-depressants, anal-
gesics and sleeping medications) to improve their sleep or
to combat pain, anxiety or insomnia. Furthermore, some
suggested that taking prescribed drugs to aid sleep was a
positive choice or a ‘‘lesser evil’’ since it prevented them
from misusing other more harmful substances:
I get headaches from lack of sleep and sometimes take
codeine to help me sleep. [Female, 52 years, no substance
use]
With the meds I get a really good sleep and don’t need
drugs or drink. [Male, 45 years, drug use]
Still others stated that taking prescribed medications
(particularly antidepressants) undermined their sleep.
Indeed, some were so worried about becoming addicted to
sleeping aids that they avoided them at all costs or only took
them ‘‘as a last resort’’:
I was prescribed anti-depressants last year. . . since then,
the sleep has got really bad.’’ [Female, 37 years, no
substance use]
I don’t want to be prescribed drugs as they’re addictive.
[Female, 56 years, drug use]
(iv) Factors improving sleep quality
Respondents who reported that they were no longer misusing
substances (especially alcohol) and/or who described them-
selves as being ‘‘in recovery’’ overwhelmingly stated that
their sleep had improved greatly since detoxing. Further, some
clarified that it had continued to improve the longer they did
not consume alcohol or other drugs and others added that it
had eventually returned to ‘‘normal’’:
Since starting detox my sleep is improving. [Male, 55
years, alcohol use]
I stopped drinking eighteen months ago and now sleep
much better. [Female, 43 years, no substance use]
I’ve been sober three years and my sleep has got
progressively better. [Female, 57 years, no substance use]
Other strategies which respondents had adopted to
improve their sleep quality, particularly to help them fall
asleep, included more daytime exercising, limiting caffeine
intake (especially later in the day), trying to have a routine
before bed, relaxing before bed, meditation, hypnotherapy,
watching television in bed, being happy, or reducing their
expectations about the kind of sleep quality they would
achieve:
Exercise helps me sleep. [Male, 30 years, drug use]
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I have stopped taking any stimulants, including alcohol,
cocaine, codeine-based over-the-counter medication and
no coffee after eleven in the morning. [Female, 42 years,
drug and alcohol use]
I had to change my expectations about what constituted a
good night’s sleep and align them with ‘‘reality’’. [Male,
47 years, no substance use]
(v) Factors undermining sleep quality
A reduction in substance use or abstinence did not, however,
guarantee restful sleep. On the contrary, some respondents
noted how their sleep had worsened during detoxification,
often due to racing thoughts and withdrawal symptoms such
as shaking, sweating and vomiting. Others explained that they
still struggled to sleep despite having already been abstinent
for a period of months or years:
When I stop drinking, I go through three to five nights and
days of shaking, unable to sleep, sweating, vivid dreams.
[Male, 65 years, alcohol use]
I have been in recovery for ten years (fully abstinent from
drugs and alcohol), but still experience poor sleep quality,
anxiety at night and traumatic dreams. [Female, 36 years,
no substance use]
Respondents often linked their sleep problems to factors
beyond their substance use; one of the most common
explanations being poor mental health, both diagnosed
mental health conditions and more generalised anxiety,
including self-perpetuating concerns about not being able to
sleep:
My sleep pattern can be disturbed by my bipolar affective
disorder. [Female, 36 years, drug use]
I believe anxiety is the key cause for my sleep problems.
[Female, 37 years, alcohol use]
Chronic pain and diagnosed sleep disorders were also
identified as undermining sleep quality. Other bodily causes
of sleep disruption included desires or cravings to eat during
the night (especially sugar), needing the toilet, experiencing
withdrawal symptoms, night sweats, cramps or having bad
dreams or nightmares:
I have a chronic pain condition that keeps me awake.
[Female, 47 years, alcohol use]
I have apnoea that can be more frequent at times and
alarming for my partner. [Male, 52 years, no substance
use]
I wake up a lot because of night sweats. [Male, 54 years,
drug use]
Many respondents additionally discussed social factors
associated with their broader life circumstances or lifestyle
that disrupted their sleep or created stresses that undermined
their sleep quality. These included having babies or small
children who cried or needed attention during the night;
family or relationship difficulties that resulted in bedtime
arguments or worries that stopped them from sleeping; past
trauma, including childhood sexual abuse that now made it
impossible to relax in bed; being homeless and feeling
unsettled and unstable; having a disrupted sleep pattern from
working nightshifts; not having a daily structure or routine;
work-related stresses; lack of exercise; being ‘‘undisciplined’’
about sleep; drinking too much caffeine; and feeling generally
unhappy:
I have a lot of stress from work keeps me awake. [Male, 58
years, no substance use]
My sleep would be better if I had more discipline. [Female,
52 years, drug and alcohol use]
I hate my life; that’s why I can’t sleep. [Female, 45 years,
drug use]
Other factors that were identified as impeding sleep were
environmental, such as living in a hostel or residential
treatment setting (particularly if others were using substances
during the night), feeling unsafe, noise, intrusive smells or
simply having an uncomfortable bed:
This environment [homeless hostel] doesn’t help me to
sleep. Too noisy and dangerous people. [Male, 45 years,
drug use]
My upstairs neighbour wakes me up every single night
with loud music. [Female, 37 years, no substance use]
Lastly, some respondents referred to being a lifetime
‘‘light’’ or ‘‘poor’’ sleeper or explained that they had always
slept ‘‘badly’’, even as a child:
I’m a light sleeper. [Male, 55 years, alcohol use]
I don’t think it’s just using drugs affecting my sleep. Even
when I was young I have had problems getting to sleep and
staying asleep. [Female, 47 years, drug and alcohol use]
Discussion
Our findings add to existing evidence that poor sleep, and
associated tiredness and exhaustion, concern many people
who use, or who have used, drugs or alcohol problematically
(Neale et al., 2012; Nettleton et al., 2011, 2017). We have also
provided further evidence that this population reports a strong
desire to sleep ‘‘better’’; thus indicating a potential willing-
ness to receive assistance with their sleep problems (BCW
condition: ‘‘Motivation’’). Our data additionally support
previous research that has highlighted the complex and
contradictory nature of sleep amongst substance users
(Nettleton et al., 2017). Indeed, our respondents routinely
reported broken sleep, disturbing dreams, nightmares, hallu-
cinations, sleeping too much, prolonged wakefulness and
difficulties falling asleep.
Many of our survey respondents recognised that substance
use undermined their sleep quality and reported that reduced
substance use or abstinence was a key factor improving their
sleep. Others believed that their use of substances,
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particularly cannabis and alcohol, facilitated their sleep.
These conflicting perspectives are not irreconcilable since the
physiological effects of different substances and different
quantities of substances on the human body are varied
(Arnedt et al., 2012; Conroy & Arnedt, 2014). Furthermore,
perceptions of sleep quality often do not align neatly with
more objective sleep measures (Kushida et al., 2001; Lockley
et al., 1999; Unruh et al., 2008). It is therefore possible for
people to believe that substances are facilitating sleep when
they may in fact be undermining it (or vice versa) (Arnedt
et al., 2012; Feinberg et al., 1975; Morgan et al., 2006;
Nicholson et al., 2004). These findings remind us that ability
to change sleep (BCW condition: ‘‘Capability’’) can be
affected ‘‘physiologically’’ and ‘‘psychologically’’ by
pharmacology.
From the above, it seems reasonable to suggest that any
intervention to address drug or alcohol-related sleep problems
might beneficially include clear information (BCW function:
‘‘Education’’) on what is currently known about the effects of
drugs and alcohol on sleep and the body. Given that
prescribed drugs are also frequently misused and can cause
addiction (Compton & Volkow, 2006; Tjagvad et al., 2016),
this information would need to encompass the effects of the
use and misuse of prescribed medications. Further, any
potential role for prescribed sleep medications (BCW func-
tion: ‘‘Enablement’’) would need careful consideration. Our
data suggest that some individuals would welcome and
potentially benefit from prescribed sleeping aids whilst others
would be too concerned about the risks of dependence (Hoyer
& Jacobson, 2013). Such discussions would need to be part of
any intervention and treatment decision-making processes.
In addition to reduced substance use, respondents identi-
fied other strategies that facilitated their sleep. Some
strategies (increased exercise, limited caffeine intake, a
bedtime routine, relaxation, meditation, hypnotherapy, chan-
ging expectations about sleep) are not novel and would be
consistent with more generic information on ‘‘sleep hygiene’’
(Irish et al., 2015). In terms of BCW functions, they might be
labelled ‘‘Education’’, ‘‘Training’’ and ‘‘Enablement’’. Other
strategies (for example, watching television in bed) are more
contentious, whilst others (for example, being happy) might
be more aspirational than practical. Although these techniques
may not all be ‘‘evidence-based’’, we should not underesti-
mate the power of personal testimony and the reassurance and
hope that can often be derived from the accounts of ‘‘experts
by experience’’ (Borkman, 1976). Any sleep intervention
should thus, whenever possible, incorporate the advice of
those who have already tried particular sleep strategies and
concluded that they work (BCW function: ‘‘Modelling’’).
One challenge to emerge from the data was the finding that
respondents who had reduced or ceased their substance use
still reported that their sleep was poor. Persisting sleep
problems after substance cessation have also been docu-
mented in the clinical literature (Brower, 2015; Hasler et al.,
2012). Whilst it may be relatively easy to explain to people
that their sleep will probably worsen during a short period of
detoxification, it is likely to be more difficult for them to hear
that their sleep will still be causing them major problems
weeks, months or even years after they have ceased using any
substances. Nonetheless, our respondents’ explanations for
these more persistent and intractable sleep difficulties reveal
critical biographical psychological, physical, social and
environmental factors that can undermine sleep (BCW
conditions: ‘‘Opportunity’’ and ‘‘Capability’’). Accordingly,
intervention developers need to look beyond substance use;
taking into account the wider range of personal circumstances
and behaviours that can impede sleep (c.f. Brower, 2015).
Respondents highlighted how their sleep was negatively
affected by poor mental health (both diagnosed mental health
conditions but also more generalised anxiety); physical health
problems (including pain and diagnosed sleep disorders);
bodily needs and functions (such as hunger, urination,
sweating and dreaming); social factors (family circumstances,
previous traumas, domestic and work-related stresses); envir-
onmental factors (poor housing or homelessness, feeling
unsafe, noise, smells, an uncomfortable bed) and personal
biographies of poor or light sleeping. Most of these problems
are unlikely to be improved by a sleep intervention conducted
in isolation. Nonetheless, identifying and discussing these
difficulties may still be instructive; enabling people to see
why their ‘‘Capability’’ and ‘‘Opportunity’’ to sleep remain
poor, despite reduced substance use or abstinence, and
clarifying wider aspects of their lives that may need to be
altered or for which they may need additional support.
Our analyses have weaknesses and strengths. Respondents
in the main survey were self-selecting and those providing
free text comments differed from those who did not on key
demographic, substance use and sleep variables. Our findings
are therefore not statistically generalisable. Furthermore, our
data were generated via a single open text box at the end of a
structured questionnaire; as such, responses lack the depth
and detail that is ordinarily achieved through qualitative
research. More positively, we successfully captured the
subjective experiences and concerns of a large number of
individuals with diverse demographic, substance use and
sleep characteristics (more so than would likely have been
possible using standard qualitative techniques). These have
produced new insights into a hitherto poorly understood topic:
current and former drug and alcohol users’ subjective
experiences of sleep and sleep quality. Moreover, the
qualitative data that participants proactively offered have –
when considered with reference to the BCW – provided useful
information to inform the design of psychosocial interven-
tions to improve sleep amongst this population.
Conclusions
Accounts of sleep provided by people experiencing problems
with drugs or alcohol offer important insights for intervention
design. Our respondents confirmed that substance use under-
mines sleep quality and quantity (Arnedt et al., 2012; Burke
et al., 2008; Escobar-Cordoba et al., 2009; Hasler et al.,
2014), but also revealed that poor sleep can persist even after
substance use has reduced or ceased. The types of sleep
problems identified were diverse; as were accounts of the
causes of, and strategies for dealing with, those problems.
Indeed, causes and strategies were rooted in biological,
psychological, social and environmental factors. Sleep inter-
ventions must therefore move beyond substance use and begin
to address these complex factors if they are to be effective.
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Mapping our findings onto the nine BCW functions
suggests that interventions should, at a minimum, include
‘‘Education’’ about drugs and alcohol and their effects on
sleep and the body; ‘‘Education’’, ‘‘Training’’ and
‘‘Enablement’’ in relation to the potential benefits of exercise,
reduced caffeine intake, bedtime routines, relaxation and the
heterogeneity of sleep needs; carefully considered
‘‘Enablement’’ via the use of sleep medications; and
‘‘Modelling’’ based on the accounts and experiences of
those who have already managed to address their sleep
problems, and those currently working to overcome sleep
problems. In terms of the broader BCW policy categories that
might facilitate sleep, organisations routinely working with
drug and alcohol users should afford sleep greater priority and
attention by offering information, advice and support (BCW:
‘‘Service Provision’’). Further, residential settings (for
example, detoxification units, rehabilitation centres, prisons
and hostels) should produce protocols on sleep etiquette in
shared sleeping spaces (BCW: ‘‘Guidelines’’) and commit to
providing clean, quiet and safe places in which everyone can
rest and recover (BCW: ‘‘Environmental/Social Planning’’)
(Nettleton et al., 2012).
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